Can Trazodone (antidepressant medication) cause false positive results for Fentanyl, Amphetamine, and Methamphetamine on drug tests?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone and False Positive Drug Screens

Trazodone can cause false positive results for amphetamines and methamphetamines on urine drug screens, but does NOT cause false positives for fentanyl. 1, 2

Mechanism of Amphetamine/Methamphetamine False Positives

  • Trazodone's metabolite meta-chlorophenylpiperazine (m-CPP) is the culprit that cross-reacts with amphetamine immunoassays, not trazodone itself 1, 2
  • This cross-reactivity occurs with multiple commercial immunoassay platforms including the Roche Amphetamines II assay and the Thermo Scientific DRI Amphetamines assay 1, 2
  • The false positive rate is clinically significant—at one institution, at least 8 trazodone-associated false-positive amphetamine results occurred during a single 26-day period 1
  • There is a strong correlation (r = 0.990) between m-CPP concentration in urine and the degree of immunoassay reactivity 1

Fentanyl Testing: No Cross-Reactivity with Trazodone

  • Trazodone does NOT cause false positive fentanyl results 3
  • The only medications documented to cross-react with fentanyl immunoassays are risperidone and its metabolite 9-hydroxyrisperidone 3
  • Fentanyl immunoassays have different specificity issues than amphetamine assays and are not affected by trazodone or m-CPP 3

Critical Clinical Action Steps

  • Order confirmatory testing using gas chromatography-mass spectrometry (GC-MS) immediately before making any clinical decisions based on a positive amphetamine screen in patients taking trazodone 4, 5
  • Obtain complete medication history specifically asking about trazodone use when interpreting any positive amphetamine/methamphetamine result 5, 6
  • Never discharge patients from practice or make punitive decisions based solely on immunoassay screening results without confirmatory testing 4

Understanding the Differential Diagnosis

When a patient taking trazodone has a positive amphetamine screen, the differential includes: 4

  • False positive from m-CPP cross-reactivity (most likely in trazodone users)
  • Actual amphetamine/methamphetamine use
  • Other medication interferences (pseudoephedrine in cold medications also causes amphetamine false positives) 6, 7
  • Laboratory error
  • Self-treatment of uncontrolled symptoms

Common Pitfalls to Avoid

  • Assuming all positive amphetamine screens represent illicit drug use is incorrect—many prescribed medications including trazodone cause false positives 5
  • Failing to recognize that standard enzyme-linked immunoassays are screening tests only with known specificity limitations 4
  • Not establishing a working relationship with your local toxicologist for consultation on complex results 4, 6
  • Making forensic interpretations of drug tests—this has no place in the patient-provider relationship 4

Additional Context on MDMA/Ecstasy Screens

  • Trazodone and m-CPP also cross-react with MDMA (ecstasy) immunoassays, causing false positive results on those screens as well 8
  • This is clinically relevant because m-CPP itself is emerging as an illicit recreational drug, adding complexity to interpretation 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trazodone and False Positive Drug Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Interpreting Urine Drug Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupropion and Urine Drug Screens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.